![Ulrich G. Traugott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ulrich G. Traugott
No más puestos en curso
Historial de carrera de Ulrich G. Traugott
Antiguos cargos conocidos de Ulrich G. Traugott.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Knoll Pharmaceutical Co. | Corporate Officer/Principal | - | - |
Glaxo Wellcome, Inc. | Director Técnico/Científico/I+D | - | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Técnico/Científico/I+D | - | - |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Director Técnico/Científico/I+D | 01/01/2006 | - |
Formación de Ulrich G. Traugott.
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Alemania | 3 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Knoll Pharmaceutical Co. |
- Bolsa de valores
- Insiders
- Ulrich G. Traugott
- Experiencia